July, 2022

article thumbnail

'Flat is the new up': After biotech correction, venture investors turn to safer bets

Bio Pharma Dive

New companies are being built more carefully and platform technologies are less in vouge as the downturn's effects ripple through the private sector

284
284
article thumbnail

Amazon’s big gamble

World of DTC Marketing

Quick Read: Amazon will dramatically expand its healthcare reach with its planned $3.9 billion acquisition of One Medical, a primary care provider with 188 offices in 25 markets nationwide but are they making a strategic move or a mistake?

Marketing 232
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin.

Insulin 262
article thumbnail

Personalizing the Cancer Patient Journey

Pharma Marketing Network

In the first two weeks after a cancer diagnosis, there are likely dozens of doctor’s visits, tests, consultations, and decision points.

Marketing 104
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

Staying Ahead of the Game in Web3: Our Latest Hackathon Win!  

Intouch Solutions

What does a EVERSANA INTOUCH Web3 hackathon win mean for the future of healthcare? It’s a grand question… but let’s explain and see if you agree with us that it’s a very big deal indeed.

article thumbnail

Is FDA Going to Get A Little Help From Its Friends at the PTO?

FDA Law Blog

By Sara W. Koblitz — Drug pricing has been a hot button issue in the U.S. for decades, and patent protections have been cited as a source of “ gamesmanship ” allowing brand companies to keep drug prices high. Yet, as long as FDA and FTC have been trying to address anticompetitive behavior, the U.S.

More Trending

article thumbnail

AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes

World of DTC Marketing

In 2020, over 75% of AbbVie’s’ sales were made to American consumers, yet only 1% of AbbVie’s’ income was reported in the United States for tax purposes.

Marketing 223
article thumbnail

Is biotech facing a long bear market?

Pharmaceutical Technology

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence.

Marketing 259
article thumbnail

Addressing Rising Rx Costs

Pharmaceutical Commerce

How did the industry get here and what alternatives can be sought out?

83
article thumbnail

Always In Beta: Building a Culture of Innovation

Intouch Solutions

article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Fast and facile synthesis of antibacterial amino acid Schiff base copper complexes

Scienmag

Ever since their development in the late 19th century, Schiff bases have been a popular group of organic compounds, owing to their wide variety of desirable properties.

article thumbnail

Vertex to move non-opioid painkiller into late-stage tests after FDA agreement

Bio Pharma Dive

Trial results released earlier this year showed potential for the drug, which has become one of Vertex’s top pipeline prospects

Trials 279
article thumbnail

The fairytale of DTC TV ads

World of DTC Marketing

The pandemic is changing consumer behavior, and there is zero chance they will return to their carefree spending ways. Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales.

Doctors 221
article thumbnail

Entrance of novel therapies will drive Niemann-Pick type C disease market growth

Pharmaceutical Technology

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31.

Marketing 247
article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

7 Most Common Types of Depression

Olympian Clinical Research

Depression is an illness that affects nearly 280 million people worldwide. There are several types of depression, each with its own set of symptoms and recommended treatment methods.

article thumbnail

AstraZeneca reports sales drop for Evusheld. Why is the variant-busting COVID med underachieving?

Fierce Pharma

AstraZeneca reports sales drop for Evusheld. Why is the variant-busting COVID med underachieving? kdunleavy. Fri, 07/29/2022 - 10:10

Sales 114
article thumbnail

“Soft” CRISPR may offer a new fix for genetic defects

Scienmag

Curing debilitating genetic diseases is one of the great challenges of modern medicine.

article thumbnail

De-risking oncology trials with medical monitoring

Bio Pharma Dive

Phase three oncology studies have approximately a 35% likelihood of leading to regulatory approval

Trials 274
article thumbnail

The continued shame of pharma

World of DTC Marketing

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses.

Marketing 214
article thumbnail

GSK acquires US-based Sierra Oncology for $1.9bn

Pharmaceutical Technology

GlaxoSmithKline (GSK) has completed the acquisition of all outstanding shares of US-based Sierra Oncology in a deal totalling $1.9bn (£1.6bn), in cash. In April this year, GSK entered an agreement for the acquisition of Sierra Oncology for $55 per share.

article thumbnail

Moderna’s Nipah virus mRNA vaccine enters Phase 1 trial

BioPharma Reporter

Moderna has dosed the first participant in a Phase 1 trial of its Nipah virus vaccine candidate, mRNA-1215, that has been developed in collaboration with the US National Institutes of Health (NIH). Bio Developments

Trials 114
article thumbnail

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Fierce Pharma

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug. zbecker. Thu, 07/21/2022 - 10:19

Drugs 113
article thumbnail

Safer web surfing with a new method for detecting malicious modes

Scienmag

With the ever-increasing importance of the Internet in our lives, there are growing attempts to exploit software vulnerabilities in our PCs for personal benefit. One way to do so is by infecting the victim’s PC with a malicious code injected through a website.

81
article thumbnail

European regulator recommends Bavarian Nordic's vaccine for monkeypox

Bio Pharma Dive

The positive decision comes as governments aim to expand supply and quicken distribution of the vaccine to combat a widening global outbreak. Separately, the EMA backed approvals of 11 other medicines

article thumbnail

Pharma’s platinum handcuffs

World of DTC Marketing

To address the “retention” problem, pharma companies are paying employees exorbitant salaries. The problem with that system is that people do whatever they need to to “hold onto” their high-paying jobs and become employees who are content not to excel.

Marketing 214
article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine.

article thumbnail

NICE recommends Rhythm’s Imcivree to help treat obesity and control hunger

Pharma Times

The treatment has been developed for people aged six years and over will be available for use across the NHS

article thumbnail

Nothing to Seagen here: Merck remains mum on merger

Fierce Pharma

Nothing to Seagen here: Merck remains mum on merger. kdunleavy. Thu, 07/28/2022 - 10:24

112
112
article thumbnail

Natural gas is key to WVU engineer’s vision for clean hydrogen energy

Scienmag

More than 50 years after scientists first coined the term “hydrogen economy,” the movement to make hydrogen a predominant global fuel source could be gaining traction, thanks to research led by one West Virginia University engineer.

article thumbnail

FDA approves new vitiligo treatment, bolstering Incyte's dermatology business

Bio Pharma Dive

The cream, known as Opzelura, is now the only treatment approved in the U.S. to repigment skin in patients with the most common form of vitiligo

article thumbnail

Are digital pharmacies the answer?

World of DTC Marketing

Digital pharmacies seem to be springing up everywhere. Allowing patients to order medications online and get delivery via Fed-Ex or the mail does offer time savings. Still, without a significant value (lower costs), they may not find an audience.

Pharmacy 206
article thumbnail

Do generics producers have what it takes to tackle complex and specialty drugs?

Pharmaceutical Technology

With decreasing margins on the horizon, pharma manufacturers have long shown an interest in specialty generics, which is only expected to rise in the future.

article thumbnail

The continued search for a cure to HIV

Pharma Phorum

Not very long ago, contracting HIV was an effective death sentence; today, there are treatments that allow the condition to be managed but not eradicated.

article thumbnail

Lilly taps Triastek to use 3D printing for gut-targeted drug delivery

Fierce Pharma

Lilly taps Triastek to use 3D printing for gut-targeted drug delivery. ntaylor. Mon, 07/18/2022 - 06:46